FDA inspection
Nicola Longo, M.D., Ph.D.: FDA inspection ending Mar 10, 2023
FDA inspection 1199605 · Voluntary Action Indicated (VAI) · Salt Lake City, UT
Key facts
| Inspection ID | 1199605 |
|---|---|
| Firm | Nicola Longo, M.D., Ph.D. |
| FEI number | 3010532531 |
| Address | 417 S Wakara Way Ste 3209 |
| City | Salt Lake City |
| State | UT |
| ZIP | 84108 |
| Country | United States |
| Fiscal year | 2023 |
| Inspection end date | Mar 10, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data